The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure-Reference-Cited by-同舟云学术

The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure

Published:2016-02-03 Issue:3 Volume:20 Page:392-398
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Chait Yossi¹,Kalim Sahir²,Horowitz Joseph³,Hollot Christopher V.⁴,Ankers Elizabeth D.²,Germain Michael J.⁵,Thadhani Ravi I.²

Affiliation:

1. Department of Mechanical and Industrial Engineering; University of Massachusetts; Amherst MA USA

2. Department of Medicine, Division of Nephrology; Massachusetts General Hospital and Harvard Medical School; Boston MA USA

3. Department of Mathematics and Statistics; University of Massachusetts; Amherst MA USA

4. Department of Electrical and Computer Engineering; University of Massachusetts; Amherst MA USA

5. Baystate Medical Center, Springfield, and Tufts University School of Medicine; MA USA

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hdi.12407/fullpdf

Reference32 articles.

1. National Kidney Foundation About Chronic Kidney Disease http://www.kidney.org/kidneydisease/aboutckd.cfm

2. Anemia in chronic kidney disease: Causes, diagnosis, treatment;Nurko;Cleve Clin J Med.,2006

3. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease;Pfeffer;N Engl J Med.,2009

4. Correction of anemia with epoetin alfa in chronic kidney disease;Singh;N Engl J Med.,2006

5. FDA Drug Safety Communication Modified dosing recommendations to improve the safe use of Erythropoiesis-Stimulating Agents (ESAs) in chronic kidney disease http://www.fda.gov/Drugs/DrugSafety/ucm259639.htm

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients;Hematology, Transfusion and Cell Therapy;2024-08

2. Impact of C-reactive protein on the effect of Roxadustat for the treatment of anemia in chronic kidney disease: a systematic review of randomized controlled trials;BMC Nephrology;2024-02-05

3. The influencing factors of the erythropoietin resistance index and its association with all-cause mortality in maintenance hemodialysis patients;Renal Failure;2024-01-17

4. The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose-Adaptation Algorithm;Journal of Pharmaceutical Sciences;2024-01

5. Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States;Kidney International Reports;2023-12